Connect with us

Health

U.S. Foreign Aid Freeze Sparks HIV Crisis as Millions Risk Losing Treatment

Published

on

The global fight against HIV/AIDS is at risk as confusion over U.S. foreign aid policy threatens access to life-saving medication for millions. A temporary waiver for the President’s Emergency Plan for AIDS Relief (PEPFAR)—a program credited with saving countless lives—has left uncertainty in its wake, raising concerns about a resurgence in AIDS-related deaths.

According to the United Nations AIDS agency, the disruption could lead to 6.3 million AIDS-related deaths over the next five years. The crisis unfolds at a time when complacency around HIV is rising, with declining condom use among young people and the emergence of preventive drugs that some believe could end AIDS for good.

The Importance of PEPFAR

Launched in 2003, PEPFAR is widely considered one of the most successful foreign aid programs in history, providing antiretroviral drugs to millions of people worldwide. However, the Trump administration’s decision to freeze foreign aid, citing concerns over wasteful spending, has thrown the program into chaos.

Hundreds of U.S.-funded health workers in Africa—including in Kenya and Ethiopia—have already been laid off, causing significant disruptions to HIV testing, care, and support. Some clinics have reportedly turned patients away, leaving them without critical medication.

The U.S. Centers for Disease Control and Prevention (CDC) stresses that without HIV treatment, people with AIDS typically survive only three years. The fear now is that delays in resolving PEPFAR’s funding status could undo decades of progress in combating the epidemic.

What Happens When HIV Treatment Stops?

HIV, which is transmitted through blood, breast milk, or semen, weakens the immune system, making individuals vulnerable to life-threatening infections. The 1980s AIDS epidemic first alerted the world to this phenomenon when rare diseases began appearing in otherwise healthy people.

See also  Early Cancer Diagnoses Reach Record High in England Amid Increased Screenings

Today, antiretroviral drugs keep HIV from multiplying in the body. Stopping treatment allows the virus to rebound within weeks, raising the risk of transmission and potentially leading to drug-resistant strains.

For pregnant women, continued treatment is critical to preventing mother-to-child transmission. Without medication, babies born to HIV-positive mothers face a high risk of infection, which can lead to severe complications and early mortality.

Without treatment, people living with HIV become susceptible to opportunistic infections such as pneumonia, tuberculosis (TB), and salmonella—diseases that can be deadly when the immune system is compromised. In countries like South Africa, which has the highest number of HIV cases and a severe TB crisis, the effects of treatment disruptions could be catastrophic.

The Urgency of Action

For years, people living with HIV have been advised to take their medication at the same time every day to prevent viral resistance. Now, that routine is in jeopardy as supply chains break down.

Health experts warn that the longer PEPFAR’s future remains uncertain, the more people will be left without life-saving drugs. Restoring lost funding, rehiring laid-off workers, and rebuilding essential health programs will take time—time that millions of people may not have.

As the international community looks to the U.S. for clarity, the fate of millions of HIV patients hangs in the balance.

Health

France Records 5,764 Excess Deaths During Deadliest Heatwave Since 2003

Published

on

At least 5,764 excess deaths were recorded in France during last month’s record-breaking heatwave, making it the country’s deadliest heat event since 2003, according to new figures from the national public health agency.

Between June 17 and July 2, 21,674 people died in France, compared with an estimated 15,910 deaths expected under normal conditions, Santé publique France said in a bulletin published Wednesday.

The agency described the figure as the highest excess all-cause mortality recorded during a heatwave since 2003. That year’s extreme heat event caused nearly 15,000 deaths across France.

The latest heatwave was notable for its timing, intensity and duration. It struck early in the summer, when schools and workplaces were still operating normally, and exposed almost the entire French population to extreme temperatures.

For the first time, the public health agency recorded excess all-cause mortality across every age group from 15 years old and above. The agency said the pattern demonstrated the exceptional intensity and prolonged nature of the heat exposure.

People aged 75 and over accounted for around two-thirds of the provisional death toll, with at least 3,719 excess deaths recorded in that age group. However, deaths also increased among younger adults, making the event different from many previous heatwaves, when the impact was concentrated mainly among the elderly.

Mortality rose in hospitals, private homes and nursing homes. Almost half of the excess deaths occurred in hospitals, according to the preliminary data.

Santé publique France stressed that the excess deaths cannot yet be directly attributed to heat in every individual case. However, the scale and distribution of the increase point to the wider health impact of the extreme temperatures.

See also  Experts Say Both Mineral and Chemical Sunscreens Are Safe When Used Properly

The agency said the findings showed the need for governments and health authorities to introduce prevention and response measures before temperatures reach crisis levels.

“These impacts highlight the importance of implementing management and prevention measures to reduce the impact of heat on the population without waiting for health impacts to become apparent,” the agency said.

The French figures came as other Western European countries reported thousands of additional deaths during a heatwave in early July. Preliminary estimates suggested more than 4,000 people died across the region during that period.

The World Health Organization’s European office called on governments at the end of June to treat extreme heat as a major health crisis and strengthen the ability of health systems to respond.

Public health officials have warned that longer and more intense heatwaves are placing growing pressure on hospitals, care facilities and emergency services, increasing the need for early warnings and stronger protection measures.

Continue Reading

Health

Up to Five Cups of Coffee a Day May Be Safe for Most Adults, Review Finds

Published

on

Drinking up to five cups of coffee a day may be safe for most adults and could be associated with a lower risk of several health problems, according to a major review by the American Heart Association.

The review found that consuming up to 400 milligrams of caffeine a day, roughly equivalent to five cups of caffeinated coffee, does not generally increase cardiovascular risk for most adults. Moderate consumption, particularly between two and four cups daily, was also linked to the lowest risk of death in the research examined.

“The equivalent of up to five cups of caffeinated coffee per day without added sugars or fillers is safe and does not increase cardiovascular risk,” said Gregory M. Marcus, a co-author of the paper and professor of medicine at the University of California, San Francisco.

The analysis found that moderate coffee consumption may be associated with better heart health and a lower risk of conditions including heart failure, heart disease and stroke. Some individuals also appeared to have a lower risk of high blood pressure and type 2 diabetes.

Coffee is the main source of caffeine for many adults, but daily intake can also come from tea, chocolate, fizzy drinks and some over-the-counter and prescription medicines. The researchers said less is known about the effects of caffeine from these sources, particularly at high levels.

Energy drinks were highlighted as an area requiring further study because large amounts of caffeine and other ingredients may pose cardiovascular risks.

Caffeine is processed by the liver and usually reaches its highest concentration in the blood within about an hour of consumption. The way people respond to it varies widely, however, depending on genetics, metabolism, age and previous caffeine intake.

See also  Study Links Navigational Tasks in Driving Professions to Lower Alzheimer’s Death Rates

Regular coffee drinkers may develop some tolerance, while others can experience strong effects from relatively small amounts.

“Although research suggests that caffeine consumption may be associated with certain cardiovascular benefits for some people, it’s important to remember that there is no ‘one-size-fits-all’ strategy for safe caffeine consumption,” Marcus said.

He added that an amount that is reasonable for one person could cause side effects such as heart palpitations, anxiety or sleep disruption in another.

The researchers also warned that the way coffee is prepared can affect its overall health impact. Large amounts of added sugar, flavoured syrups and high-calorie dairy products can significantly increase calorie intake and may reduce the potential benefits associated with coffee itself.

The findings suggest that moderate, unsweetened coffee consumption can fit into a healthy lifestyle for many adults, but individual tolerance remains an important factor when deciding how much caffeine to consume.

Continue Reading

Health

Summer Heat Linked to Seasonal Depression as Mental Health Concerns Rise Worldwide

Published

on

Seasonal depression is commonly associated with the short, dark days of winter, but health experts are warning that hot weather and prolonged heatwaves can also trigger a lesser-known form of the condition during the summer months.

Medical professionals say Summer Seasonal Affective Disorder (SAD) is a recognised type of depression that follows a seasonal pattern and can significantly affect daily life. Although far less common than winter SAD, experts stress that it should be treated as a serious mental health condition.

According to a recent study, summer SAD affects around 0.57% of the global population, compared with about 5% for the winter form of the disorder. Rising temperatures, frequent heatwaves and tropical nights have been identified as factors that can contribute to symptoms in vulnerable individuals.

Unlike winter depression, which is often linked to reduced daylight and social isolation, summer SAD is associated with excessive heat, disrupted sleep and physical discomfort. Symptoms may include insomnia, loss of appetite, anxiety, agitation and persistent low mood. In severe cases, the condition can interfere with work, relationships and everyday activities.

Adam Borland, a clinical psychologist at the Cleveland Clinic, said people experiencing symptoms may benefit from maintaining a regular daily routine, limiting exposure to extreme heat and making sleep a priority. He added that anyone with severe or persistent symptoms should seek professional medical care.

The warning comes as mental health conditions continue to rise across the world. A recent analysis from the Global Burden of Disease Study, published in The Lancet, estimated that approximately 1.2 billion people, or around 15% of the global population, were living with a mental health condition in 2023.

See also  Study Finds Calorie Restriction Can Boost Chemotherapy Effectiveness in Sarcoma Treatment

The study found that the number of people affected by mental health disorders increased by 95% between 1990 and 2023. During the same period, mental disorders climbed from the 12th to the fifth leading cause of health loss worldwide.

Major depressive disorder and anxiety disorders recorded some of the sharpest increases. Cases of major depression rose by 131%, while anxiety disorders increased by 158%, making them the two most common mental health conditions globally.

Researchers behind the Global Burden of Disease Study said meeting the growing demand for mental health services should be regarded as a public health priority, particularly for vulnerable groups.

The situation is also a concern across Europe. The World Health Organization estimates that one in six people in the European region, around 140 million individuals, lives with a mental health condition. Despite the high number of cases, only one in three people suffering from depression receive the treatment they need.

Health experts have also highlighted the lasting impact of the COVID-19 pandemic. Depression and anxiety among young people have increased by an estimated 25% since the pandemic, while suicide has become the leading cause of death among people aged 15 to 29 in the European region.

Continue Reading

Trending